U.S. Commercial Pharma


Model N U.S. Commercial Pharma is the only integrated software solution that helps you maximize and grow revenues with comprehensive capabilities and embedded analytics.

LSv4.jpg

'(data-builder-id='C3FCB9E1-039E-4EFB-ACDE-AEBCF2F0BDAC', data-bislr-stylable='areaAD7CA29226684B08A7E22054045DF97D')

Solutions that Optimize Pharma Revenue


Group purchasing across providers and regions, hospital and pharmacy consolidation, and generic price competition are eroding profitable commercial sales and challenging effective GPO, IDN, hospital and pharmacy contracting.


To succeed in this highly competitive and complex area, pharma manufacturers need infrastructure that allows them to easily:

  • Structure and create performance-based contracts and innovative incentives 

  • Offset revenues compromised by competition

  • Ensure they are paying the correct amount of rebates and that contract terms are being enforced


Solutions that Optimize Pharma Revenue

Control Your Gross-to-Net, Maximize Profitable Revenues


Model N's end-to-end commercial pharma revenue management suite is the only integrated software solution that manages customer and channel pricing, contracting, rebating, chargebacks and embedded analytics throughout the product lifecycle and across your organization. 

Maximize Revenue, Reduce Revenue Leakage Risk


Model N offers an integrated suite of applications and industry best practices that helps life sciences companies by managing every dollar that impacts their top line.


Model N leverages its deep industry expertise to support the unique business needs of life sciences companies in more than 50 countries.

Customers include Actavis, Allergan, Amgen, Bristol-Myers Squibb, Johnson & Johnson, Merck, Novartis, and Novo Nordisk.


Customers include Actavis, Allergan, Amgen, Bristol-Myers Squibb, Johnson & Johnson, Merck, Novartis and Novo Nordisk.

Learn More